NCT06239961Completed
Behavioral Activation, Nutrition, and Activity Intervention
Multi-Component Behavioral Activation, Nutrition, and Activity Intervention for Persons Aging With HIV
Source: ClinicalTrials.gov · Last updated 4 Jul 2025
Brief summary (registry, in English)
This study will explore if a behavioral intervention program to assist people aged 50 and older with HIV is practical. The program includes a coach who talks with participants, encouraging them to be more active, reduce loneliness, and eat healthier.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 7 (actual)
- First submitted
- 6 Dec 2023
- Start date
- 23 Sept 2024
- Primary completion date
- 19 Jun 2025
- Lead sponsor
- University of Maryland, Baltimore
- Diseases
- HIV
- NCT number
- NCT06239961
What you commit to
- Study type: Interventional
- Participants enrolled: 7
- From 23 Sept 2024 to the primary completion date, 19 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\) No severe cognitive impairment
Who the study is looking for
- 50 years of age or older
- HIV positive diagnosis
- Montreal Cognitive Assessment score \> 13
- Report minimal level of loneliness, isolation, and/or depression (PHQ9 \> 5)
- Able to consent
- Ability to read or speak English
- Attend the UM THRIVE Center or another HIV center in Baltimore
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Maryland, Baltimore Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.